Clinical Study
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
Table 3
Adverse events following transarterial chemoembolization (TACE) (48 treatments in 30 patients).
| Variable | |
| Number of TACE/patient (mean, range) | 1.6 (1–7) | Adverse events (%) | | None | 20 (42) | Yes | 28 (58) | Minor events, number of TACE (%) | 24 (50) | Pain in right upper quadrant | 18 (38) | Nausea/emesis | 7 (15) | Chemical arteritis | 5 (10) | Corticosteroids-related diabetes unbalances | 2 (4) | Ischemic hepatitis | 2 (4) | Leucocytosis | 1 (2) | Fever | 1 (2) | Allergic reaction | 1(2) | Major events, number of TACE (%) | 7 (15) | Ischemic cholecystitis | 2 (4) | Transient acute hepatic failure | 2 (4) | Thrombosis of superficial femoral artery | 1 (2) | Splenic infarction | 1 (2) | Ischemic atrophy of the left hepatic lobe | 1 (2) | Acute renal failure | 1 (2)* | Spontaneous bacterial peritonitis | 1 (2)* | Sepsis | 1 (2)* | Death | 1 (2)* |
|
|
*Those events occurred in the same patient.
|